Treatment success rate for patients treated for MDR-TB in Singapore
Singapore: Treatment success rate for patients treated for MDR-TB was 39.0% in 2022. ▼ Falling
Latest (2022)
39.0%
Change on year
up 18.2%
World rank
150th
of 163 countries
All-time high
100.0%
in 2002
All-time low
26.0%
in 2016
Years of data
20
2002–2022
Treatment success rate for patients treated for MDR-TB in Singapore, 2002–2022
Source: World Health Organization, Global Health Observatory.
Analysis
In 2022, treatment success rate for patients treated for mdr-tb in Singapore stood at 39.0%.
The figure is up 18.2% on the previous year and down 29.1% over ten years.
Over the whole period, treatment success rate for patients treated for mdr-tb in Singapore peaked at 100.0% in 2002 and was at its lowest, 26.0%, in 2016.
Singapore ranks 150th of 163 countries on this measure, in the bottom quarter.
The long-run direction has been consistently falling across the 20 years of available data.
Treatment success rate for patients treated for MDR-TB in Singapore, year by year
| Year | Value | Change |
|---|---|---|
| 2002 | 100.0% | — |
| 2003 | 60.0% | -40.0% |
| 2004 | 50.0% | -16.7% |
| 2006 | 67.0% | +34.0% |
| 2007 | 75.0% | +11.9% |
| 2008 | 100.0% | +33.3% |
| 2009 | 100.0% | +0.0% |
| 2010 | 100.0% | +0.0% |
| 2011 | 83.0% | -17.0% |
| 2012 | 55.0% | -33.7% |
| 2013 | 27.0% | -50.9% |
| 2014 | 50.0% | +85.2% |
| 2015 | 38.0% | -24.0% |
| 2016 | 26.0% | -31.6% |
| 2017 | 59.0% | +126.9% |
| 2018 | 47.0% | -20.3% |
| 2019 | 44.0% | -6.4% |
| 2020 | 38.0% | -13.6% |
| 2021 | 33.0% | -13.2% |
| 2022 | 39.0% | +18.2% |
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 78.9% | 50.0% | 100.0% | 7 |
| 2010s | 52.9% | 26.0% | 100.0% | 10 |
| 2020s | 36.7% | 33.0% | 39.0% | 3 |
Countries ranked near Singapore
- 147 Germany 45.0% compare
- 147 Argentina 45.0% compare
- 149 Bolivia, Plurinational State of 42.0% compare
- 151 Papua New Guinea 33.0% compare
- 151 Bosnia and Herzegovina 33.0% compare
- 151 Guyana 33.0% compare
- 151 Trinidad and Tobago 33.0% compare
More health data for Singapore
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.5225 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,924 deaths per 1,000 people (2090)
- Number of infants who die before age 1 13 deaths (2100)
- Population ages 15-19, male, annual growth rate -10.39 % change on previous year (2025)
- Population ages 15-19, male, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 15-19, male, per capita 0.0274 units per person (2025)
- Population ages 20-24, female, annual growth rate -3.19 % change on previous year (2025)
- Population ages 20-24, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 20-24, female, per capita 0.0396 units per person (2025)
Frequently asked questions
- What is treatment success rate for patients treated for mdr-tb in Singapore?
- Treatment success rate for patients treated for mdr-tb in Singapore was 39.0% in 2022, according to World Health Organization, Global Health Observatory.
- What is the highest treatment success rate for patients treated for mdr-tb recorded in Singapore?
- The highest recorded value was 100.0% in 2002.
- What is the lowest treatment success rate for patients treated for mdr-tb recorded in Singapore?
- The lowest recorded value was 26.0% in 2016.
- How does Singapore rank for treatment success rate for patients treated for mdr-tb?
- Singapore ranks 150th out of 163 countries with data for 2022.
- Is treatment success rate for patients treated for mdr-tb rising or falling in Singapore?
- Over the last ten years it is down 29.1%. The long-run trend across the full record is falling.
- Where does this Singapore data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Treatment success rate for patients treated for MDR-TB (%). Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 20 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).